Inactive Instrument

Insiders Aimmune Therapeutics, Inc.

Equities

AIMT

US00900T1079

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Aimmune Therapeutics, Inc. Announces Executive Changes	20-10-19	CI
Aimmune Therapeutics, Inc. Appoints Andrew Oxtoby as President	20-10-14	CI
Aimmune Therapeutics, Inc. Appoints Andrew Oxtoby as CEO	20-10-14	CI
Aimmune Therapeutics, Inc. Appoints Narinder Singh as Executive Vice President of Technical Operations	20-07-06	CI
Aimmune Therapeutics Appoints Andrew Oxtoby as Chief Commercial Officer, Effective January 22, 2019	19-01-18	CI
Aimmune Therapeutics Announces Appointment of Brett Haumann to Board of Directors, Effective October 31, 2018	18-11-02	CI
Aimmune Therapeutics, Inc. Announces Management Changes	18-06-11	CI
Aimmune Therapeutics Expands Scientific Advisory Board	18-02-14	CI
Stephen Dilly Plans to Retire as CEO of Aimmune Therapeutics, Inc by the End of 2018	17-11-06	CI
Aimmune Therapeutics Appoints Eric Bjerkholt as Chief Financial Officer	17-04-13	CI
Aimmune Therapeutics Appoints Scientific Advisory Board	16-12-01	CI
Aimmune Therapeutics, Inc. Appoints Greg Behar to Board of Directors	16-11-04	CI
Aimmune Therapeutics, Inc. Appoints Daniel Adelman, M.D., as Chief Medical Officer	16-06-21	CI
Aimmune Therapeutics Appoints Douglas Sheehy as General Counsel and Secretary	16-04-05	CI
Aimmune Therapeutics, Inc. Announces Executive Appointments	16-01-11	CI
Aimmune Therapeutics, Inc. Appoints Jeffrey H. Knapp as Chief Operating Officer, Effective from on or About February 1, 2016	15-12-17	CI
Aimmune Therapeutics, Inc. Announces Retirement of Howard Raff as Chief Operating Officer, Effective from October 31, 2015	15-10-09	CI
Allergen Research Corporation Announces Board Appointments	15-05-18	CI
Allergen Research Corporation Announces Executive Appointments	15-04-21	CI
Allergen Research Corporation Expands Management Team	15-04-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Aimmune Therapeutics, Inc.

Equities

AIMT

US00900T1079

Insiders

Filters